|
|
D/A |
2025-08-26 13:28:06 UTC |
- Amount To Be Raised
- $15,000,000
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001827388
- Filed Document
- 0001770413-25-000001
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2025-08-26 13:28:06 UTC
- Type of Offering
- D/A
- Industry
- Biotechnology
- Principal Place of Business
- Z4
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2024-07-23 12:08:27 UTC |
- Amount To Be Raised
- $5,000,000
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001827388
- Filed Document
- 0001827388-24-000001
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2024-07-23 12:08:27 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- Z4
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D/A |
2023-03-15 10:45:17 UTC |
- Amount To Be Raised
- $15,000,000
- Associated Brokers / Dealers
- Umergence LLC, KEMA Partners LLC, Keiretsu Forum Singapore, and Keiretsu Forum Mumbai
- CIK Number
- 0001827388
- Filed Document
- 0001827388-23-000002
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2023-03-15 10:45:17 UTC
- Type of Offering
- D/A
- Industry
- Biotechnology
- Principal Place of Business
- Z4
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2021-06-14 18:11:00 UTC |
- Amount To Be Raised
- $15,000,000
- Associated Brokers / Dealers
- Umergence LLC, KEMA Partners LLC, Keiretsu Forum Singapore, and Keiretsu Forum Mumbai
- CIK Number
- 0001827388
- Filed Document
- 0001827388-21-000001
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2021-06-14 18:11:00 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- ONTARIO, CANADA
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2020-10-08 17:57:41 UTC |
- Amount To Be Raised
- Indefinite
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001827388
- Filed Document
- 0001827388-20-000001
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2020-10-08 17:57:41 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- Z4
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Option To Acquire
|